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Abstract
Background:  Elevated plant sterol accumulation has been reported in the spontaneously
hypertensive rat (SHR), the stroke-prone spontaneously hypertensive rat (SHRSP) and the Wistar-
Kyoto (WKY) rat. Additionally, a blood pressure quantitative trait locus (QTL) has been mapped
to rat chromosome 6 in a New Zealand genetically hypertensive rat strain (GH rat). ABCG5 and
ABCG8 (encoding sterolin-1 and sterolin-2 respectively) have been shown to be responsible for
causing sitosterolemia in humans. These genes are organized in a head-to-head configuration at the
STSL locus on human chromosome 2p21.
Methods: To investigate whether mutations in Abcg5 or Abcg8 exist in SHR, SHRSP, WKY and GH
rats, we initiated a systematic search for the genetic variation in coding and non-coding region of
Abcg5 and Abcg8 genes in these strains. We isolated the rat cDNAs for these genes and
characterized the genomic structure and tissue expression patterns, using standard molecular
biology techniques and FISH for chromosomal assignments.
Results: Both rat Abcg5 and Abcg8 genes map to chromosome band 6q12. These genes span ~40
kb and contain 13 exons and 12 introns each, in a pattern identical to that of the STSL loci in mouse
and man. Both Abcg5 and Abcg8 were expressed only in liver and intestine. Analyses of DNA from
SHR, SHRSP, GH, WKY, Wistar, Wistar King A (WKA) and Brown Norway (BN) rat strains
revealed a homozygous G to T substitution at nucleotide 1754, resulting in the coding change
Gly583Cys in sterolin-1 only in rats that are both sitosterolemic and hypertensive (SHR, SHRSP
and WKY).
Conclusions: The rat STSL locus maps to chromosome 6q12. A non-synonymous mutation in
Abcg5, Gly583Cys, results in sitosterolemia in rat strains that are also hypertensive (WKY, SHR
and SHRSP). Those rat strains that are hypertensive, but not sitosterolemic (e.g. GH rat) do not
have mutations in Abcg5 or Abcg8. This mutation allows for expression and apparent apical targeting
of  Abcg5 protein in the intestine. These rat strains may therefore allow us to study the
pathophysiological mechanisms involved in the human disease of sitosterolemia.
Published: 3 June 2003
BMC Cardiovascular Disorders 2003, 3:4
Received: 24 January 2003
Accepted: 3 June 2003
This article is available from: http://www.biomedcentral.com/1471-2261/3/4
© 2003 Yu et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media 
for any purpose, provided this notice is preserved along with the article's original URL.BMC Cardiovascular Disorders 2003, 3 http://www.biomedcentral.com/1471-2261/3/4
Page 2 of 19
(page number not for citation purposes)
Background
The human disorder of sitosterolemia, also known as phy-
tosterolemia (MIM 210250), is an autosomal recessive
disorder characterized by the marked elevation of plasma
phytosterols e.g. β-sitosterol, campesterol and stigmas-
terol [1,2]. Hypercholesterolemia primarily during child-
hood, accelerated atherosclerosis in some adult patients
leading to premature death, as well a hemolytic anaemia,
arthralgias and tendon and tuberous xanthoma forma-
tions are other clinical features. Studies have shown that
the sitosterolemic patients hyperabsorb all sterols (choles-
terol and phytosterols) and fail to excrete phytosterols
into bile [3–7]. Positional mapping of the STSL locus to
human chromosome 2p21 led to the identification of two
genes, ATP binding cassette (ABC) half-transporters G5
and G8 that were mutated in affected individuals [8–12].
The protein products of these two genes (sterolin-1 and
sterolin-2 respectively) are thought to form heterodimers
to constitute a functional transporter, based primarily on
the genetic evidence that affected individuals are either
completely mutated in sterolin-1 or sterolin-2, but not
both [12]. More recently, evidence from in vitro expres-
sion of these proteins has been presented that these two
proteins co-immunoprecipitate, supporting this conclu-
sion [13]. ABCG5 and ABCG8 appear to be present in all
mammalian genomes examined to date and are highly
conserved between species, indicating that these genes
may have a similar function in other species. In order to
identify naturally occurring animal models of sitostero-
lemia, we previously reported a screen of 20 in-bred
mouse strains [14]. This screen showed considerable
genetic variation at these loci in the mouse strains, but
none of these strains exhibited sitosterolemia. However, a
literature search revealed that a few strains of rats, studied
primarily for investigation of hypertension and stroke,
have been reported to be sitosterolemic as well [15,16].
We hypothesised that these rat strains may be mutated in
either Abcg5 or Abcg8. Tissue (and plasma) plant sterol
levels in the Wistar Kyoto (WKY) rat, the spontaneously
hypertensive rat (SHR) and the stroke-prone spontane-
ously hypertensive rat (SHRSP) were significantly higher
than in Wistar and WKA rats fed either a regular chow diet
or diets that have higher plant sterols and these were cor-
related with increased death, or red cell hemolysis etc.
[15–22]. Dietary sterol absorption rates were increased,
with a decrease in sterol excretion [16], characteristics
similar to that observed in sitosterolemic patients.
In this study, we report the gene structure organisation,
cDNA and tissue expression patterns of rat Abcg5 and
Abcg8. Using fluorescence in situ hybridization, the rat
STSL locus was assigned to the chromosomal 6q12. Inter-
estingly, a cluster of 2 blood pressure (BP) quantitative
trait loci (QTL) in (GH × BN) F2 with LOD scores 4.63
(tail BP) and 6.82 (intra-arterial BP) has also been
reported to map to rat chromosome 6 between D6Mit3
and D6Mit12, an area containing the STSL locus. We inter-
rogated this region for genetic variations and found a cor-
relation between sitosterolemic strains and a missense
mutation in Abcg5.
Methods
DNA Samples of rat strains
The DNA samples from the following rat strains were
used: Sprague Dawley (SD, Charles River Laboratories,
Wilmington, MA), Wistar (Sea: Wistar, Outbred, SPF, Seac
Yoshitomi) and WKA (WKA/Sea, inbred, SPF, Seac Yoshi-
tomi), WKY (WKY/NCrj, inbred, SPF, Charles River Japan,
Kanagawa, Japan or Charles River, Wilmington, MA),
SHR/Crl (Charles River, Wilmington, MA), SHRSP
(SHRSP/Sea, inbred, SPF, Seac Yoshitomi, Fukuoka,
Japan), GH and BN. The genomic DNAs from GH and BN
rats were a kind gift from Dr. E. L Harris (New Zealand).
The liver tissue genomic DNAs from SD, WKY and SHR
rats were extracted by digestion overnight at 55°C in lysis
buffer (10 mM Tris pH8.0, 100 mM NaCl, 50 mM EDTA,
0.5% SDS and 0.2 mg/ml proteinase K) followed by phe-
nol-chloroform extraction and ethanol precipitation.
Genomic analysis and determination of exon-intron 
boundaries
Rat cDNAs for Abcg5 and Abcg8 were identified previously
by amplification of these sequences from a Sprague Daw-
ley rat enterocyte cDNA library, using primers located in
areas conserved between mouse and human (Genbank
AF312714 and AF351785 respectively). For Abcg5, the
first PCR fragment was obtained by PCR using primers,
ABCG5 F4, 5'-ATCCTCAAAGATGTCTCCTTGTAC-3', and
ABCG5 R3, 5'-TCCTGACTCTCCTGGTCGCT-3'. For Abcg8
cDNA sequences, the primers, F11 5'-AGATGCTGGCCAT-
CATAGGG-3' and R13 5'-GATGGAGAAGGTGAAGTT-
GCC-3', were used to amplify rat Abcg8 cDNA fragments.
These products were sequenced and used to design prim-
ers specific for rat cDNA and a rat intestinal cDNA library
was screened by anchor PCR.
Direct sequencing of the PCR products led to the identifi-
cation of rat cDNA sequence and allowed for design of rat
specific primers (Table 1, see Additional file 1). Based
upon the structure of mouse genes, putative rat-specific
exonic primers were designed and used to amplify rat
genomic regions as previously described. All PCR prod-
ucts were directly sequenced and both strands were
sequenced as a routine. The complete rat genomic
sequences have been deposited with GenBank
(AY145899).BMC Cardiovascular Disorders 2003, 3 http://www.biomedcentral.com/1471-2261/3/4
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Chromosomal localisation by fluorescence in situ hybridi-
zation (FISH)
For FISH analysis, metaphase chromosomes were pre-
pared from rat embryo fibroblasts. The cells were cultured
in DMEM medium at 37°C for 2 days and treated with
0.05 µg/ml colcemid for 45 min. The cells were harvested
by mitotic shake-off and resuspended in 0.075 M KCl at
room temperature for 10 min. Fixation was carried out as
described previously [23].
Fluorescence in situ hybridization (FISH) was performed
essentially according to Pinkel et al [24] with minor mod-
ifications [25]. The rat sequences used for FISH labelling
were amplified genomic DNA fragments (Abcg5 exons 6–
10, primers RG5-F6 and RG5-R10, and Abcg8 exons 4–13,
primers RG8-F4 and RG8-R13, Table 1, see Additional file
1). The two gene fragments were labelled separately with
digoxigenin-11-dUTP (Boehringer Mannheim, Germany)
by nick-translation (Life Technologies Inc., Gaithersburg,
MD). Appropriate length (50 to 500 bp) of the nick trans-
lated fragments was monitored by checking the nick-
translation products on a 1 % agarose gel. The two gene
fragments were precipitated separately using 800 ng of
labelled DNA with 20 µg unlabeled rat Cot1 DNA, which
was included in order to suppress probe hybridization to
repetitive sequences. The probe DNA mixtures were etha-
nol precipitated and dissolved in hybridization buffer (50
% formamide, 2 × SSC, 10 % dextran sulphate). After
denaturation, the highly repetitive sequences in the probe
mixture DNA were allowed to bind to the Cot1 DNA (10
min at 37°C). The probe mixtures were then applied to rat
fibroblast metaphase chromosome slides (previously
denatured at 73°C for 2 min in 70 % formamide, 2 ×
SSC). Hybridization was allowed to proceed in a moist
chamber for 70 h at 37°C. Subsequently, the slides were
washed for 15 min at 45°C in 55 % formamide, 2 × SSC,
and then in 2 × SSC (pH 7.0) at 43°C for 9 min. The
labelled probe molecules were detected with rhodamine
anti-digoxigenin (Oncor, Inc., Gaithersburg, MD) and the
slides were washed 3 times in PBS and 0.1 % Nonidet NP-
40. Finally, chromosome spreads were counterstained
with 4,6-diamino-2-phenylindole (DAPI, 0.5 µg/ml) in
an antifade solution (Vectashield®, Vector Laboratories,
Inc., Burlingame, CA). The images were captured using
the LEICA DM RXA in combination with the Q-FISH soft-
ware for microphotography.
Tissue expression of Abcg5 and Abcg8
A rat multiple tissue Northern blot (Origene Technolo-
gies, Rockville, MD) containing immobilised poly A+
mRNA from Sprague Dawley rat was used. Rat sterolin
cDNA probes were labelled and hybridization and wash-
ing steps were performed as described previously [26].
Total tissue RNAs were extracted from multiple tissues
from a Sprague Dawley rat using Trizol reagent as
described previously. Random hexamers were used as
primers for reverse transcription of 2 µg of rat RNA from
the multiple tissues. The primers were annealed to tem-
plate at 25°C for 10 min, and the reaction were incubated
at 53°C for 1 h in the presence of Superscript Reverse tran-
scriptase, 5 mM dNTP mix and RN'ase Out inhibitor. The
rat  Abcg5-specific primers (RG5c-F1 and RG5Fc-R1),
Abcg8-specific primers (RG8c-F1 and RG8c-R1) and β-
actin primers (sense: 5'-CTACGTCGCCCTGGACTTC-
GAGC-3', antisense: 5'-GATGGAGCCGCCGATC-
CACACGG-3') were used for further PCR amplification
(an initial denaturation at 94°C for 3 min, 35 cycles of
PCR amplification with each cycle consisting of 30 min at
94°C, 45 s at 60°C, and 2 min at 72°C, followed by an
extension step of 72°C for 5 min). The resultant PCR
products were gel-purified and sequenced.
Real-Time PCR
For quantitation, real-time PCR was employed. Primers
used were based upon previously published mouse
primer sets [27,28], or designed using MacVector from
cDNA sequences between exons, avoiding the amplifica-
tion of potentially contaminating genomic DNA in the
total RNA sample (Table 2). Samples of total RNA (2 µg)
from rat livers were reverse transcribed according to the
SuperScript' First-Strand Synthesis System (Invitrogen,
Carlsbad, CA) using random hexamers with a final vol-
ume of 20 µl. Real-time PCR was performed on a PE Bio-
systems GeneAmp 5700 sequence Detection System
(Forest City, CA). Standard reaction volume was 10 µl and
contained 1X QuantiTect SYBR Green PCR master mix
(Qiagen, Valencia, CA), 0.002 U AmpErase UNG enzyme
(PE Biosystems, Forest City, CA), 0.7 µl of cDNA template
and 100–500 nM of oligonucleotide primers. Initial steps
of RT-PCR were 2 minutes at 50°C for UNG erase activa-
tion, followed by a 15 minute hold at 95°C. Cycles (n =
40) consisted of a 15 second melt at 95°C, followed by a
1 minute annealing/extension at 60°C. The final step was
a 60°C incubation for 1 minute. All reactions were per-
formed in triplicate. Threshold cycle (CT) analysis of all
samples was set at 0.5 relative fluorescence units.
The relative amounts of Abcg5, Abcg8, Cyp7a1, HMG-CoA
reductase, and Srebp-2 message from rat liver samples
used in real-time RT-PCR were normalised to GAPDH
expression levels to compensate for variations in input
RNA amounts. The data were analysed using the compar-
ative threshold cycle method (CT) method. Briefly, the CT
values were averaged, from triplicate determinations,
defining a ∆-CT value calculated by taking the average CT
of the gene of interest and subtracting it from the average
CT of GAPDH. The ∆∆-CT was calculated by subtracting
the average ∆-CT(calibrator) values from the ∆-CT(sam-
ple). The relative quantification was then calculated by
the expression 2(Average∆∆CT). The mRNA quantity for theBMC Cardiovascular Disorders 2003, 3 http://www.biomedcentral.com/1471-2261/3/4
Page 4 of 19
(page number not for citation purposes)
calibrator (SD samples) is expressed as 1X sample and all
other quantities are expressed as a fold difference relative
to the calibrator (SD samples).
Total membrane protein preparations
Approximately 500 mg of liver tissue cut into small pieces
was homogenised in ice cold lysis buffer (5 mM Tris-
pH7.5, 250 mM sucrose with protease inhibitors PMSF,
Leupeptin, Aprotinin) by a dounce homogenizer times10
strokes. Samples were then subjected to centrifugation
1000 g for 10 minutes at 4°C. The supernatant was saved.
The pellet was resuspended and subjected to dounce
homogenisation by10 strokes, centrifuged at 1000 g for
10 minutes at 4°C and this step was repeated once more.
The supernatants from all three steps were pooled and
subjected to ultracentrifugation at 100,000 g for 40 min-
utes at 4°C, and the pellet was resuspended in 25 mM
Tris-pH7.5, 150 mM NaCl, 0.1% TritonX-100 and 0.1%
SDS, by passaging through a 25-gauge needle. Membrane
protein concentrations were determined by a colorimetric
assay according to manufacturer's protocol (BioRad, Her-
cules, CA) and 20 µg of total membrane proteins resolved
by 7.5% SDS acrylamide gel.
Immunoblotting and Immunolocalization
Proteins resolved by SDS-PAGE were transferred to nitro-
cellulose membranes and the membranes blocked for 2
hours in 5% dry milk in PBS-T (Phosphate Buffered saline
and 0.1% Tween 20). Blots were then probed with a pri-
mary rabbit anti-peptide (116-VNGCELRRDQFQDCCV-
SYLLQS-136) antibody against rat sterolin-1 (1:1000
dilution) overnight at 4°C. The blot was washed once for
5 minutes in PBS-T, incubated with goat-anti-rabbit con-
jugated HRP (1:10000 dilution) for 1 hour, washed for 5
minutes in PBS-T and developed with Western Lightning
Chemiluminescence Reagent Plus (PerkinElmer Life Sci-
ences, Inc. Boston, MA).
Snap-frozen rat liver and intestine tissues were sectioned
to 8 µm thickness using a cryotome (Bright), air-dried for
30 min and keep at -80°C until used. The slides were
stained with hematoxylin. Fixation was performed by
Table 1: Sequence of the rat Abcg5 and rat Abcg8 intron-exon boundaries
Exon Exon size (bp) Sequence of exon-intron boundaries Intron Intron size (bp)
Abcg5
1 145 TCAGCGTCAGgtaaggggacccca...gatttcctttaaagCAACCGTGTC 1 612
2 121 GGTAGCTCAGgtaagcgcctcgag...ttgtcgcccctgagGCTCAGGGAA 2 5000
3 136 CCTCCTGCAGgtgggcgtgtccct...cccctttcctgcagAGCGATGTCT 3 86
4 98 CGACAAGAAGgtacttttagttaa...tgtgtctcttacagGTAGAGGCAG 4 2320
5 132 CAGGACCCCAgtaagtgggacaca...ttctttgctggcagAGGTCATGAT 5 1317
6 139 GCTCTTCCACgtaagggaacaccc...tgtggtccaatcagCACTTCGACA 6 901
7 130 GATTTCTACAgtaagtgcattttt...ggggaaacttttagTGGACTTGAC 7 699
8 213 TTCTCCTGAGgtaagagccttgga...catttggttttcagGAGAGTAACG 8 104
9 205 GTGAACCTCTgtaagtgcctgtgt...gccttccatgccagTTCCCATGCT 9 836
10 138 TGTGTTACTGgtaaggtggtgtcc...tcgtgtttttctagGACTCTGGGC 10 2810
11 185 GATTTATCAGgtaagaagaaatga...ttctctttcttaagAAACATAGAA 11 4500
12 112 TTCACTTGTGgtaagtatcctatt...cttctccttggcagGTGGCTCCAA 12 1705
13 193
Abcg8
1 62 GGATGCTTCAgtgagtgacctagt...ctgtctcccagcagAGCCTCCAGG 1 3190
2 101 CACCTACCAGgtaggggcacatgc...acaatctgctctagGGTGGCACAT 2 623
2b 66 ATCTGAATCTgtgagttcccggtt...acctctccccacagGTGGACATGG 2b 1114
3 156 GGGAGCGCAGgtaccacagagacc...ttctgggtttgcagGCTGCGGGAG 3 3000
4 240 AGACAAACGGgtaaccagtgggct...cagcctgccctcagGTGGAAGACG 4 442
5 130 TGGAACCCAGgtgaggcctgggaa...gcgataccccccagGAATCCTCAT 5 86
6 269 GACTTCTACGgtgagtgagtaaag...tcttctgcttgcagTGGACTTGAC 6 2200
7 162 ATGCAGTCAGgtactgagagaagc...actgttcccaacagCCAGACCCTC 7 81
8 79 CCCTGATCCGgtaaatcaacctct...ttcctttctttcagTCGTCAGATT 8 1234
9 202 GTCTCCAAATgtgagtgtcacccg...tcccccatctccagCACTCGGAGC 9 165
10 73 CTTTGCCAAGgtcagggccaggag...gctgtgctttgcagGTCCTCGGTG 10 552
11 267 CTGTGGATAGgtgaggcctgcccc...cttgctgtcttcagTACCTGCATG 11 1205
12 127 CGGAGACGCGgtacgtagcgaggg...gtctgtgtccgcagATGGTCACTG 12 87
13 134
Exon sequences are shown in uppercase letter; intron sequences are in lowercase. The underlined sequence at the donor and acceptor sites of 
Abcg8 intron 1 are identical to mouse.BMC Cardiovascular Disorders 2003, 3 http://www.biomedcentral.com/1471-2261/3/4
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incubating samples for 10 min with cooled methanol at -
20°C and washed with PBS three times. The slides were
treated with blocking solution (10% goat serum in 0.1 M
glycine/PBS) for 30 min., primary antibody applied and
incubated overnight at 4°C. The slides were washed with
PBS and secondary antibody (goat-anti-rabbit FITC conju-
gated) was applied for 20–30 min at room temperature,
washed and the signals captured and analyzed using an
Olympus BX-50 microscope with Fluoview software. The
fluorescent stained images were observed under blue filter
excitation and capture excitation images at 488 nm
wavelength.
Nucleotide polymorphisms in Abcg5 and Abcg8 genes
Direct sequencing of PCR amplified genomic fragments
was performed as described previously [11]. The 5' flank-
ing region, all the exons and the 3'UTR region, as well as
the introns of Abcg5 and Abcg8 with size less than 1 Kb,
were individually amplified using primers, as described in
Table 1. The amplified PCR products were sequenced by
the use of an automated capillary sequencer. The Sprague
Dawley nucleotide sequence of Abcg5 and Abcg8 was
regarded as wild-type. Comparisons to mammalian stero-
lins (GenBank accession Nos. AF312713, AF312714,
AF312715, AF324494 AF324495, AF351785) as well as
Fugu (GenBank No. CAAB01001529), was made using
ClustalW [29].
Results
Genomic organisation and chromosome mapping of the 
rat STSL locus
Rat cDNA sequences for Abcg5 and Abcg8 were isolated
and characterized as indicated in Methods. Based upon
the known conservation between the murine and human
STSL loci [14], we designed oligonucleotides in putative
exonic regions and used PCR amplification of rat genomic
region to characterise the genome organisation. Figure 1
shows a summary composite of the genomic organisation.
The intron-exon boundary sequences are indicated in
Table 2. In keeping with the human and mouse STSL loci,
the rat Abcg5 and Abcg8 genes are arranged in a head-to-
head configuration, with a distance of 379 bp separating
their respective initiation codons. The exact start transcrip-
tional sites for either gene has not been definitively estab-
lished. Comparison of the DNA sequence of isolated
cDNAs, as well as the polypeptide sequence with human
and mouse sequences revealed a very high degree of
homology (>80%). To assign the chromosomal location,
we performed FISH analyses, and we were able to unam-
biguously map the rat STSL locus to chromosome 6q12
(Fig. 2). There is specific labelling of both chromatids of
both homologues of rat chromosome (RNO) 6 (Fig. 2A
and 2B). Based on the DAPI-banding pattern the Abcg5
and  Abcg8  genes were sub-localized to RNO6q12. The
STSL locus was mapped to the same position as shown by
the diagrammatic representation of the rat Chr. 6 as
shown in Fig. 2. The human ABCG5 and ABCG8 genes are
present in a group of 18 genes ABCG5, ABCG8, SLC8A1,
PRKR, GCKR, KHK, PPP1CB, APOB, POMC1, SDC1,
MYCN, DDX1, VSNL1, RRM2, ODC1, ID2, TPO and
ACP1 in the region HSA2p21-p25, and this group is also
present on RNO6. Thus, the ABCG5 and ABCG8 genes fit
into a group of genes that are syntenic both in HSA2 and
in RNO6. A conserved segment between HSA2, RNO6,
and MMU17 on RNO6q11-q16 has been demonstrated
by Zoo-FISH analysis and gene mapping data, confirming
this synteny [30–32].
Expression patterns of rat Abcg5 and Abcg8 mRNAs
Rat  Abcg5 and Abcg8 mRNA expression patterns were
determined, using a commercial multiple tissue poly A+
Northern filter. Expression appeared mainly to be con-
fined to the liver (Fig. 3A), with dominant transcripts sizes
of ~2.5 kb for Abcg5 and of ~4.5 kb for Abcg8. However,
the poly A+ RNA loaded onto this Northern blot has been
adjusted to obtain an identical β-actin signal, and the
intestinal RNA loaded may thus have less enterocyte RNA.
Using a more sensitive RT-PCR analyses of RNA obtained
from different tissues confirmed that rat Abcg5 and Abcg8
genes were expressed in both in the liver and small intes-
tine, with a low level of expression in the colon (Fig. 3B).
Table 2: Oligonucleotide primers used for real time PCR or rat sequences
Target
Gene
Primer Sequence Length of 
Amplicon
GenBank™ 
accession no.
Abcg5 Forward: 5'-AGGCTCAGTTACAGGCTCAGAG-3' Reverse: 5'-GTCCCACTTCTGCTGGCATGAT 118 bp AF312714
Abcg8 Forward: 5'-CGTCAGATTTCCAATGACTTCCG-3' Reverse: 5'-TCCGTCCTCCAGTTCATAGTACA-3' 241 bp AF351785
Cyp7a1 Forward: 5'-CAGGGAGATGCTCTGTGTTCA-3' Reverse: 5'-AGGCATACATCCCTTCCGTGA-3' 121 bp NM_012924
HMG-CoA
Reductase
Forward: 5'-GAACTGAAACACGGGCATTGG-3' Reverse: 5'-ACGGCACGGAAAGAACCATAG-3' 189 bp X55286
Srebp-2 Forward: 5'-TGGAAGGAAGGTAGAGTAGGTGGG-3' Reverse: 5'-TTTTGTGGACTGCTTGGCT-
CAGGG-3'
152 bp AA901364
GAPDH Forward: 5'-TCAAGAAGGTGGTGAAGCAGGC-3' Reverse: 5'-GCATCAAAGGTGGAAGAATGGG-3' 118 bp AF106860BMC Cardiovascular Disorders 2003, 3 http://www.biomedcentral.com/1471-2261/3/4
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Additionally, while screening an enterocyte cDNA library
for full length cDNAs using PCR, we consistently ampli-
fied two DNA products when using Abcg8 primers flank-
ing exon 2; one of the expected size, and another very low
copy product ~60 bases larger. Direct sequencing of these
products confirmed both of these contained Abcg8 rat
cDNA sequences, but the larger product contained a 66 bp
insertion, resulting in a predicted in-frame addition of 22
amino acids, between exons 2 and 3. To confirm that this
insertion resulted from an alternatively spliced mRNA, we
amplified and sequenced the intragenic region between
exons 2 and 3 and identified a 66 bp exon (exon 2b),
flanked by canonical splice-sites (see Table 1 and Fig. 4).
We next screened total liver and intestinal RNA, using RT-
PCR, from SD, SHR and WKY rats (Fig. 4). In all samples
a larger DNA fragment of low abundance was identified
(Fig. 4) and direct sequencing showed that these frag-
ments contained exon 2b sequences (data not shown). It
is not established whether these transcripts are a result of
aberrant splicing, or are translated and code for a slightly
larger sterolin-2. Careful interrogation of the mouse and
human genomic sequences did not identify any homolo-
gous sequences, suggesting this is unique to the rat. Addi-
tionally, both the mouse and human Abcg8 genes have
alternatively spliced mRNA, involving a CAG repeat at
exon 2 and exon 8 splice acceptor sites respectively
[12,14]. However, despite the presence of such a repeat at
the rat exon 2 splice acceptor site for Abcg8 (Table 1), none
of the rat mRNAs showed any heterogeneity of splice-site
selection at this site.
Hypertensive rats have sitosterolemia and a mis-sense 
change in Abcg5
A number of different groups have reported that geneti-
cally hypertensive strains of rats (SHR, SHRSP, WKY) have
elevated levels of plasma sitosterol [15–22]. Although the
WKY strain is not considered hypertensive, dietary altera-
tions involving plant sterols appear to increase blood
pressure in this strain [21]. We screened two commercially
available hypertensive rats, as well as a 'genetically hyper-
tensive' strain, GH, for plasma plant sterol levels and com-
pared these to two control strains, Sprague-Dawley and
Wistar (Table 3). Our analyses confirmed that WKY, and
SHR are sitosterolemic on a chow diet, but neither the
control strains, nor the GH rat showed any significant
differences.
Figure 1
Organisation of the rat Abcg5 and Abcg8 genes The top line indicates the restriction endonuclease map of the STSL locus; 
B, Bam HI; E, EcoRI; S, Sal I, X, XbaI. The second line indicates Abcg5 and Abcg8 gene organisation, with the vertical lines repre-
senting exons, numbered as shown. The 379 bp separating 5'ends of Abcg5 and Abcg8 is indicated. The direction of transcrip-
tion of Abcg5 and Abcg8 is as indicated by the arrows, resulting in mRNAs indicated on the line below. The gray portions 
indicate the UTRs for Abcg5 and Abcg8. The polypeptides are depicted with the predicted transmembrane spanning regions, as 
well as the A, B and C Walker motifs, characteristic for the ABC family of protein.BMC Cardiovascular Disorders 2003, 3 http://www.biomedcentral.com/1471-2261/3/4
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To identify if alterations at the STSL locus could account
for these observations, we amplified and directly
sequenced Abcg5 and Abcg8 from Wistar, Sprague-Dawley,
WKY, WKA, GH, SHR, and SHRSP rats. Table 4 shows a
compilation of both coding and non-coding alterations
detected. There were 24 polymorphic changes detected in
Abcg5 and 14 polymorphic changes in Abcg8. However,
only one non-synonymous nucleotide change, G1754T,
resulting in a conservative cysteine substitution for glycine
at amino acid 583 (Gly583Cys) in sterolin-1 was identi-
fied (Fig. 5A). This 'mutation' was only detected in SHR,
SHRSP and WKY rats and was present in all of these strains
as a homozygous change (Table 4). These hypertensive
strains also shared uniquely 4 other nucleotide changes
not present in the other strains (Table 4). These latter
changes were confined to intronic areas and the 3'UTR
region. Although the intronic changes are unlikely to alter
the biology of these genes, the 3' UTR insertion in Abcg8
mRNA could be important, if message stability were
affected. This possibility was not formally investigated.
The identified G1754T (Gly583Cys) missense mutation
of the Abcg5 generates loss of a restriction site for Hae III
after PCR amplification of exon 12, and this allowed a
PCR-RFLP assay to further confirm the detected change
(Figure 5B). Note that the DNA chosen from a single Wis-
tar rat was heterozygous for almost all of these changes.
The amino acid G583 is conserved between all known
mammalian sterolin-1 proteins (Fig. 5C) and its altera-
tion may have functional consequences, as it is also con-
served in evolution, being conserved in the Fugu fish (Fig.
5C). Fugu sterolin-1 shows a 55% homology to rat stero-
lin-1 at the amino acid level, and its gene structure is also
organized in a similar fashion (data not shown). Cur-
rently, a gap in the Fugu genomic sequence has not been
completed that may encode for exon 2. The complete
Fugu  STSL  locus is available on-line (GenBank No.
CAAB01001529).
In Abcg8, a large insertional polymorphism was identified
in exon 13, that resulted in the insertion of 143 nucle-
otides in the 3'UTR (*2099_2100ins143nt). WKY, SHR,
Figure 2
Chromosomal mapping by FISH A representative photograph of the FISH analyses, shows the localisation of rat Abcg5 
(panel A) and Abcg8 (panel B) to both pairs of chromosome 6 in a metaphase spread (arrows). An ideogram of rat chromo-
some 6 showing the mapped position of both Abcg5 and Abcg8 genes (vertical bar) is shown at the right hand side.BMC Cardiovascular Disorders 2003, 3 http://www.biomedcentral.com/1471-2261/3/4
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SHRSP and GH rats are homozygous, Sprague Dawley and
WKA strains wild-type and the Wistar sample hetero-
zygous for this polymorphism (Fig. 6).
Comparison of expression of Abcg5 and Abcg8 in hyper-
tensive rat strains
Expression levels of Abcg5 and Abcg8 in these rat strains
were examined in two ways. For mRNA expression, quan-
titative real time PCR was utilised, and for protein, west-
ern blotting analyses, as well as immunohistochemistry
was employed. Fig. 7 shows the results of the real time
PCR assays of liver RNAs from fasted animals. Using
GAPDH mRNA expression as a control, expression of
Abcg5 and Abcg8 mRNAs appeared to be increased in liver
from SHR compared to Sprague Dawley (Fig. 7), the
message for Cyp7 a1 (except for Wistar and WKY) HMG
CoA reductase, SR-B1, and SREBP-2 (except for SHR) were
relatively unchanged. Interestingly, the message for LDL-R
was reduced in both WKY and SHR livers.
To compare protein expression levels of the sterolins, we
performed western blotting. A reliable antibody to stero-
lin-1 was available only and was used to probe liver
microsomal lysates from Sprague Dawley, SHR and Wistar
rats (Fig. 8). Although equal amounts of microsomal
protein lysates were loaded from the livers of these differ-
ent strains, we consistently observed that the protein
expression patterns were always different between SHR
and the control strains (Fig. 8, panel C, cf. tracks 5, 6 and
8). Thus, all of the data were normalised in one of two
ways, either by using total microsomal protein, or by
using the intensity of transferrin signal, after western blot-
ting. Both of these methods gave consistent results and
indicated that expression of Abcg5 was increased approxi-
mately 2-fold in the SHR but not the Wistar or SD (Fig. 8).
To further assess if the mutant protein is mis-targeted, we
performed immunolocalization, using an anti-peptide
rabbit antibody, on various rat liver and intestinal sec-
tions (Fig. 9). We did not observe any differences between
the staining patterns observed for the control rat strains
Figure 3
Expression analyses of rat Abcg5 and Abcg8 Panel A, Northern blot analyses of poly (A)+ RNA from a variety of rat tis-
sues (see Materials and Methods) showed that expression of Abcg5 (top panel) and Abcg8 (middle panel) was confined mainly to 
liver. Panel B, RT-PCR analyses confirmed the liver expression pattern, but further showed that both Abcg5 and Abcg8 were 
also expressed in the small intestine and colon, but not in any other tissues screened. As a control, β-actin expression was 
used in both Northern and RT-PCR analyses.BMC Cardiovascular Disorders 2003, 3 http://www.biomedcentral.com/1471-2261/3/4
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(Wistar or SD) and the mutant hypertensive strains (SHR,
SHRSP). Interestingly, we observed a clear apical staining
pattern for Abcg5 in the intestine and this was not altered
in the mutant strains (Fig. 9, panel B).
Discussion
Recent studies on ABC transporters have significantly
advanced our understanding of intestinal sterol absorp-
tion and biliary excretion [33]. Sterols are essential con-
stituents of cellular membranes in human, animals and
plants. In humans and animals, cholesterol is the sterol
that is synthesised, absorbed and utilised, whereas plants
do not synthesise cholesterol, but use molecules that are
similar, such as sitosterol, campesterol and stigmasterol.
Although similar amounts of cholesterol and plant sterols
are present in the typical human diet, the intestine of nor-
mal subjects provides an efficient barrier against the
absorption of the majority of plant sterols [3]. On average,
< 1–5% of dietary plant sterols are absorbed and retained
compared with ~55% of dietary cholesterol [3,34]. Thus,
in healthy individuals, there exists an exquisite mecha-
nism that allows the body to distinguish between choles-
terol and non-cholesterol sterols. ABCG5 and ABCG8 are
two genes located adjacently in a head-to-head configura-
Figure 4
Alternative splicing of Abcg8 mRNA expression in SD, SHR and WKY rats by RT-PCR Panel A shows the gene 
organisation of Abcg8, and below it the organisation of an alternatively spliced form detected by sequencing clones from a rat 
intestinal cDNA library (see Text). Panel B shows that the effect of the inclusion of exon 2b in the mRNA results in an in-frame 
addition of 22 amino acids. Total RNAs were prepared from liver and small intestine from SD, SHR and WKY rats maintained 
on a standard rodent chow diet and analysed by RT-PCR with primers (see Methods) based outside the alternatively spliced 
exon 2b. Direct amplification of a pooled cDNA library sample indicated a major DNA product of 396 bp, with a minor prod-
uct of 462 bp, containing exon 2b. DNA products, using cloned wild type Abcg8 cDNA (wt) and alternatively spliced cDNA 
(AS) are shown in tracks 3 and 4 respectively. As can be seen, liver and intestine RNA from all three strains show a minor 
DNA product of 462 bp (confirmed by sequencing) contained the insertion of exon2b sequences.BMC Cardiovascular Disorders 2003, 3 http://www.biomedcentral.com/1471-2261/3/4
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tion on human chromosome 2p21, encoding for two half-
transporters, sterolin 1 and sterolin 2 respectively
[9,10,12]. Mutations in either of these genes causes sito-
sterolemia, characterized by hyperabsorption of phyto-
sterols, reduced excretion of sterols into the bile and very
elevated levels of plasma plant sterol levels. In sitostero-
lemic patients, the absorption of phytosterols in intestine
is dramatically increased, with absorption of plant sterols
to about the same extent (~60%) as cholesterol.
Interestingly, a similar whole-body accumulation of plant
sterols, less severe than in human sitosterolemia, has been
reported recently in SHR, SHRSP and WKY rats, but not in
the other genetically related rat strains, such as SD, Wistar
and WKA rats [16]. These rats exhibit defects at two levels:
increased absorption of sterols (plant and animal) at the
intestinal level and decreased excretion of sterols into bile
[16]. The higher sterol absorption in the intestine and the
lower biliary excretion of plant sterols in these rat strains
led us to hypothesise that Abcg5 or Abcg8 gene mutations
may be responsible for the sitosterolemia observed in
these hypertensive rats.
Characterization of the rat STSL locus showed that it is
highly conserved in organization, and maps to rat chro-
mosome 6q12, a region also syntenic with the mouse and
human STSL loci. Rat Abcg5 and Abcg8 are expressed in a
tissue-specific manner, with expression confined to the
liver and the intestine. We sequenced the STSL loci in
sitosterolemic and control rat strains and identified a
number of nucleotide changes. Most of these nucleotide
changes were in intronic regions and, based upon their
locations, are likely to be 'silent'. However, one change,
G1754T in exon 12 was identified that led to a coding
change of Gly583Cys in sterolin-1 (Abcg5). This change
was found only in rat strains that were confirmed to be
sitosterolemic (WKY, SHR and SHRSP), but not in any of
the other strains screened (SD, Wistar, WKA, GH or BN).
The significance of other genetic variances in Abcg5 and
Abcg8 in different rat strains documented in this study is
presently unknown. Plant sterol metabolism has been
extensively evaluated in different rat strains, but the accu-
mulation of plant sterols occurs only in SHR, SHRSP and
WKY rats. The predicted 6 trans-membrane domain
model of sterolin-1 indicates that the Gly583Cys missense
mutation is located within the third extracellular loop
(residues 554–620), in a conserved region (Fig 5C) and is
adjacent to two potential N-glycosylation sites (residues
585 and 594). Thus a mutation at residue 583 could dis-
rupt the first site. Finally, both the sterolin-1 and sterolin-
2 are cysteine-rich proteins (16 cysteines in sterolin 1 and
14 in sterolin 2), five of these cyteines in sterolin-1 are
present in the extracellular loop containing the mutation.
It is tempting to speculate that the gain of an additional
cysteine in sterolin-1 by the Gly583Cys missense muta-
tion might affect intracellular trafficking or the
heterodimerization with sterolin-2. This possibility is
diminished but not eliminated by the demonstration that
in both the mutant and control rats, Abcg5 is located api-
cally in the intestine (Fig. 9). Evidence that sterolin-1 and
sterolin-2 may heterodimerize has now been presented,
based upon in vitro analyses [13]. However, our prelimi-
nary analyses of immunohistochemistry, using an anti-
body to sterolin-1 suggests that the pattern of expression
in the liver and intestine is similar for both SD as well as
Table 3: Sterol compositions in SD, Wistar, GH, WKY and SHR rats a
Tissues Total sterol mg/dL or mg/g Cholesterol mg/dL (%) Campesterol mg/dL (%) Sitosterol mg/dL (%) Total plant sterol mg/dL (%)
Plasma
SD 57.8 54.6 (94.5) 1.30 (2.2) 1.95 (3.4) 3.3 (5.5)
Wistar 96.3 92.0 (95.5) 1.90 (2.0) 2.40 (2.49) 4.3 (4.47)
GH 88.9 84.0 (94.5) 2.24 (2.5) 2.62 (2.54) 4.9 (5.47)
WKY 76.5 63.4 (82.9) 4.40 (5.8) 8.65 (11.3) 13.1 (17.1)
SHR 68.6 58.3 (85.0) 4.00 (5.8) 6.25 (9.11) 10.3 (15.0)
Liver
SD 1.77 1.72 (97.1) 0.03 (1.4) 0.03 (1.58)) 0.05 (2.99)
Wistar 1.62 1.55 (95.4) 0.04 (2.2) 0.04 (2.47) 0.08 (4.60)
WKY 2.33 2.10 (90) 0.09 (4.2) 0.14 (6.05) 0.24 (10.0)
SHR 2.06 1.85 (90) 0.09 (4.1) 0.12 (5.83) 0.21 (9.95)
Brain
SD 11.0 10.95 (99.6) 0.02 (0.2) 0.02 (0.15) 0.03 (0.6)
Wistar 13.8 13.73 (99.5) 0.02 (0.1) 0.04 (0.31) 0.06 (0.45)
WKY 12.2 12.15 (99.6) 0.02 (0.2) 0.03 (0.25) 0.05 (0.40)
SHR 11.8 11.76 (99.7) 0.02 (0.2) 0.01 (0.05) 0.03 (0.25)
a The rats (n = 2 for SD, Wistar, WKY and SHR; n = 4 for GH) were 11 weeks old and in regular rodent chow diet.BMC Cardiovascular Disorders 2003, 3 http://www.biomedcentral.com/1471-2261/3/4
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WKY or SHR rats (Fig. 9). These studies are limited in
scope, as antibody reagents to detect rat sterolin-2 are not
currently available.
Another formal possibility not excluded is that the
Gly583Cys missense mutation may have no significance
in the accumulation of phytosterols in WKY, SHR and
SHRSP, and that the alteration in the 3' UTR or even the
intronic changes reported above may be the causative
'mutations'. Our analyses of the mRNA and protein pro-
files would not strongly support these possibilities. How-
ever, further investigation will be required to determine if
the 3-base insertion in the predicted 3'UTR of Abcg8 has
any functional consequence. In the absence of a direct
assay for sterolin-1 and -2 function, the genetic changes
presented, together with the correlation of the pheno-
types, remains the strongest evidence that these genetic
alterations are functional, and that the Gly583Cys is a
mutational change.
A more relevant question raised in this study is whether
the plant sterol accumulation in hypertensive rat strains
has significance in the pathophysiology of hypertension.
Recent linkage mapping studies mapped hypertension
Table 4: Polymorphic changes at the STSL locus identified in different rat strains
Gene Position Nucleotide changea Effectb
Wistar WKA WKY SHR SHRSP GH
Abcg5 5'-UTR -99A>G - ±√
Intron1 IVS1-8delC - √√√ √ √
IVS1-95 A>C - √√√ √ √
IVS1-258 A>G - √√√ √ √
Intron3 IVS3+14 T>C - √√√ √
Intron4 IVS4+86 T>C - √√√ √
Intron5 IVS5+70 A>G - √√ √
IVS5-90 C>T - √√√ √
Intron6 IVS6+64 C>T - √√ √
Exon7 856 C>T G283G √√ √
Exon8 1061 C>T L352L ±√√ √ √ √ √
Intron8 IVS8+10 delC - √√√ √
IVS8-171 C>T - √
Exon9 1265 C>T R420R √√ √ √ √√
1288 T>C L427L √√ √ √
Intron10 IVS10+60A>G - √√√ √ √
IVS10+97 G>C - √√√ √ √
IVS10+99 G>T - √
Intron11 IVS11+24 T>G - √√
IVS11+33 delG - √√
Exon 12 1754 G>T G583C √√ √
3'-UTR *251 T>C - ±√
*261 C>T - ±√
*353 C>A - ±√√ √ √ √
Abcg8 Intron 1 IVS1+399 A>C - ±√√ √ √ √
IVS1+558 C>A - √√ √
IVS1-53 A>G - ±√√ √ √ √ √
Intron 6 IVS6-34 G>A - √√ √
Intron 9 IVS9+13 C>T - ±√√ √ √ √
IVS9+75 C>T - √
3'-UTR *101 C>T - ±√√ √ √
*1461 A>G - ±√√ √ √
*1458 T>C - ±√√ √ √ √
*1777_1778insAGG - √√ √
*1781 T>G - √√ √ √
*1799 A>G - ±√√ √ √
*1967 G>T - ±√√ √ √
*2099_2100ins143 nt - ±√√ √ √ √
±√ indicates for heterozygous, √ for homozygous a Numbering based as indicated in Table 1, see Additional file 1b Numbering based upon the first 
ATG as +1 All sequences are same as that of Sprague Dawley, unless indicated by the check mark. Sequence in bold indicates the coding change.BMC Cardiovascular Disorders 2003, 3 http://www.biomedcentral.com/1471-2261/3/4
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Figure 5
Demonstration of G1754T (Gly583Cys) mutation in SHR, SHRSP and WKY rats. Panel A shows a representative 
sequence electropherogram from SD, Wistar, WKA, GH and BN rats (top electropherogram) and from SHR, SHRSP and 
WKY rats (bottom electropherogram) for exon 12 of Abcg5. A homozygous change (G1754T, Gly583Cys) is present in the 
sitosterolemic rats and this mutation abolishes the recognition site for restriction enzyme Hae III. Panel B shows the restriction 
fragment analyses of DNA amplified from these different rat strains, further confirming the presence of the mutational change. 
In the absence of digestion a 252 bp PCR product is present, which, after Hae III digestion (wt) results in two products of 180 
bp and 72 bp (indicated by the arrows). The sitosterolemic strains WKY, SHR and SHRSP (lanes 6–8) are all resistant to diges-
tion by Hae III, but SD and Wistar remain sensitive (lanes 3 and 4). Lanes 1 and 10 shows molecular weight markers, and lanes 
2 and 9 show undigested PCR products (252 bp) from SD rat and SHRSP respectively. Panel C shows the alignment of amino 
acids 565 to 592 of sterolin-1 from human, mouse, rat and Fugu. An arrowhead indicates the position of Gly583Cys mutation.BMC Cardiovascular Disorders 2003, 3 http://www.biomedcentral.com/1471-2261/3/4
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QTLs to a number of chromosomal regions in SHR and
SHRSP rats [35]. Our FISH study assigned the STSL locus
rat chromosome 6q12, a region where a cluster of blood
pressure QTL with Lod score 4~6 has been reported to be
present (M6MIT12-M6MIT3, 39 cM distance) in a New
Zealand genetically hypertensive rat (GH rat) [35]. With
respect to hypertension, although the SHR and SHRSP
strains carry the Gly583Cys mutation, in extensive QTL
Figure 6
Insertional polymorphisms in rat Abcg8 exon 13. Panel A shows the sizes of PCR products amplified using primers that 
amplify the 3'-UTR of Abcg8. Two distinct products of 1.11 Kb and 1.252 Kb bands were noted. SD and WKA were 
homozygous for the 1.11 kb size, while WKY, SHR and SHRSP were homozygous for the 1.25 kb size. Interestingly, the sample 
from a Wistar rat was heterozygous for this change. Direct sequencing of the larger product showed a 143 bp insertion at 
position 2099 in the 3' UTR of Abcg8 (panel B).BMC Cardiovascular Disorders 2003, 3 http://www.biomedcentral.com/1471-2261/3/4
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mapping studies using these strains, no loci mapping to
the rat STSL region have been reported [35]. In our study,
the GH rat is neither sitosterolemic, nor has any nucle-
otide alteration at the STSL locus that would implicate
this region as mutated. Thus we do not believe the STSL
locus plays a role in determining blood pressure. How-
ever, it may play a significant role in modifying the
pathophysiology.
Studies reported by different investigators have shown
that a dietary intake of 10 % canola oil (as part of semi-
purified diets) significantly shortened the life-span of
SHRSP rats, with accumulation of phytosterols in plasma,
Figure 7
Real time PCR quantification of selected rat mRNAs. Real time PCR and quantitation of message abundance was per-
formed as described in Methods. Relative to the levels in livers from SD rats, expression of mRNAs for both sterolins was 
increased ~3–5 fold in the SHR livers, as was the message for Srebp-2 (~2 fold). No significant change in SR-B1 or Cyp7a1 for 
SHR compared to SD liver RNAs was noted. However, the expression of LDL-R was reduced in both WKY and SHR rats.BMC Cardiovascular Disorders 2003, 3 http://www.biomedcentral.com/1471-2261/3/4
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Figure 8
Protein Expression of Abcg5 in liver total membrane preparations. Membrane preparations (20 µg protein) from rat 
tissues were isolated and analysed by SDS-PAGE, blotted and probed with anti-Abcg5 antiserum (R116, panel A), probed with 
anti-transferrin antiserum (panel B) or the gel was fixed and stained with Coomassie Brilliant Blue R-250 (panel C). Lane 1 con-
tains a recombinant E. coli expressed N-terminal fragment of sterolin-1 as a control for antibody binding, lanes 2 and 3 contain 
Sprague-Dawley (SD) spleen membrane extracts. Liver from Wistar (lanes 4 and 5), SHR (lanes 6 and 7) and Sprague-Dawley 
(SD, lanes 8 and 9) Densitometry measurements when normalised to transferrin show a 2-fold increase in sterolin-1 protein in 
SHR rat liver samples, compared to SD and Wistar rat liver. No antibody for sterolin-2 is currently available.BMC Cardiovascular Disorders 2003, 3 http://www.biomedcentral.com/1471-2261/3/4
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Figure 9
Immunohistochemical detection of Abcg5 in liver and intestine from different rat strains. The panels on the left 
hand show liver sections and those on the right hand show intestinal sections. The right hand images of each panel show the 
hematoxylin stained images, viewed with transmitted light and the left hand images show the fluorescence images captured at 
the same laser wavelength and intensity. Panel A shows results obtained with the pre-immune serum, panel B, C and D the 
results for Wistar, WKY and SHR rat tissues. All sections were captured at 40 × magnification. Scale bars (50 µm) are shown 
in the bottom left hand corner of each image. The data for SD rat tissues were similar to those obtained with Wistar and are 
not shown.BMC Cardiovascular Disorders 2003, 3 http://www.biomedcentral.com/1471-2261/3/4
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red blood cells and tissues [15,17–19,21,22]. Lower red
blood cell (RBC) membrane deformability, lower density
of platelets, as well as a higher blood pressure were also
observed, when compared to a SHRSP group fed with veg-
etable oils lower in phytosterols (10 % soybean oil vs.
10% canola oil). Canola oil has a higher sitosterol content
than soybean oil. In comparison, extensive studies on
evaluation of high phytosterol diets in SD rats (non-sito-
sterolemic) have consistently shown to be safe without
any adverse consequences [36–42]. These intriguing dif-
ferences between SHRSP and SD rats may now be
explained, at least in part, by presence of the Gly583Cys
missense mutation in sterolin-1. The WKY rat also carries
this mutation and a high dietary intake of phytosterols
will also increase the blood pressure and decrease the den-
sity of platelets, though to a lower extent than that
observed in SHRSP rats [20]. These data support a patho-
logical role of elevated plant sterols in these rats and sup-
port the notion that the STSL loci evolved to not only
allow for the excretion of cholesterol into bile, but also to
keep 'xeno-sterols' from accumulating in the body. With
respect to sitosterolemia in humans, although
atherosclerotic complications have been well-described,
hypertension has not been mentioned as feature. How-
ever, it is not known whether the atherosclerosis in sito-
sterolemic patients with hypertension is accelerated,
relative to those affected individuals with lower blood
pressures.
The Gly583Cys mutation in Abcg5 is likely to have origi-
nated in the original outbred Wistar colony bred in Kyoto
(from which WKY was subsequently derived), which has
been widely employed as a normotensive control in
experimental studies of hypertension. It gave rise to the
SHR and SHRSP strains. Thus, this mutation in WKY, SHR
and SHRSP lines may not contribute to the hypertension
phenotype  per se, but may only be responsible for
sitosterolemia. The original Wistar colony was established
at the Wistar Institute in 1906, and the Sprague Dawley
colony was derived by Dawley in approximately 1925
from a single male of unknown origin and a Wistar
female. The SHR strain was derived by selective inbreed-
ing from the Kyoto outbred Wistar colony, and both SHR
and SHRSP, as well as WKY strains have been maintained
over many generations through brother-sister matings
http://rgd.mcw.edu/tools/strains[43,44]. Healthy WKA
and GH rat strains were also generated from outbred Wis-
tar rat strains, but these strains were isolated independ-
ently in Japan and New Zealand, respectively (and
maintained at other sites as well). The GH rat was selected
for systolic hypertension that increased with successive
generations and maintained through filial matings [45].
In view of this, the Gly583Cys missense mutation of
Abcg5 might result from occurrence of a de novo mutation
during breeding at the stage of developing inbred WKY
strains and propagated into the SHR and SHRSP lines. In
contrast, the 143 nucleotide fragment insertion polymor-
phism in the 3'-UTR of Abcg8 may have resulted from
acquisition of a foreign chromosomal fragment during
the Wistar rat strain breeding and established as
homozygous change in the WKY, SHR and SHRSP, as well
as GH rat strains. In this context, it is important to note
that 3 other mutant loci have been reported in the SHR
rat; missense mutations in the KAT-1 (kynurenine ami-
notransferase-1), Srebf-1 (sterol regulatory element bind-
ing factor-1) and CD36  (fatty acid translocase) are all
present as homozygous changes [46–48]. The generation
of congenic lines may assist with addressing many of these
issues. Such lines will be useful in demonstrating that the
variant sterolin-1 protein is responsible for causing sito-
sterolemia, but will allow comparisons between animals
that are hypertensive and those that are hypertensive and
sitosterolemic. Currently, there are no appropriate genetic
controls available, as SHR, SHRSP and WKY are all main-
tained as colonies by brother-sister matings. While this
manuscript was in review, Scoggan et al also reported
identifying Gly583Cys alteration in Abcg5 of SHR, SHRP
and WKY rats [49].
Conclusion
Three rat strain, WKY, SHR and SHRSP, that are hyperten-
sive are also sitosterolemic. All of these strains are
homozygous mutant for Gly583Cys in sterolin-1,
encoded by Abcg5. This mutation is not present in rats that
were not sitosterolemic, even though one of these was
hypertensive (the GH rat). The rat STSL locus, comprising
of Abcg5 and Abcg8, maps to rat chromosome 6q12, a
region syntenic with both mouse and human STSL loci.
Preliminary antibody studies show that this mutant pro-
tein is expressed and appears to be apically targeted in the
intestinal cells.
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